84 results on '"Schouten, N."'
Search Results
52. Is there an end of the “learning curve” of endoscopic totally extraperitoneal (TEP) hernia repair?
- Author
-
Schouten, N., primary, Simmermacher, R. K. J., additional, van Dalen, T., additional, Smakman, N., additional, Clevers, G. J., additional, Davids, P. H. P., additional, Verleisdonk, E. J. M. M., additional, and Burgmans, J. P. J., additional
- Published
- 2012
- Full Text
- View/download PDF
53. NEUROPSYCHOLOGY
- Author
-
Brinkman, T., primary, Liu, W., additional, Armstrong, G., additional, Gajjar, A., additional, Merchant, T., additional, Kimberg, C., additional, Kun, L., additional, Srivastava, D. K., additional, Gurney, J., additional, Robison, L., additional, Hudson, M., additional, Krull, K., additional, Rubens, J., additional, Lulla, R. R., additional, Lai, J.-S., additional, Fangusaro, J., additional, Wolfe, K., additional, Madan-Swain, A., additional, Reddy, A., additional, Hunter, G., additional, Banos, J., additional, Kana, R., additional, Resch, A., additional, von Hoff, K., additional, von Buren, A. O., additional, Friedrich, C., additional, Treulieb, W., additional, Lindow, C., additional, Kwiecien, R., additional, Ottensmeier, H., additional, Rutkowski, S., additional, Armstrong, C. L., additional, Phillips, P. C., additional, Lustig, R. A., additional, Stamos, C., additional, Li, Y., additional, Belasco, J., additional, Minturn, J. E., additional, Fisher, M. J., additional, Heinks-Maldonado, T., additional, Wingeier, K., additional, Lory, V., additional, Schafer, C., additional, Studer, M., additional, Steinlin, M., additional, Leibundgut, K., additional, de Ruiter, M., additional, Schouten, N., additional, Greidanus, J., additional, Grootenhuis, M., additional, Oosterlaan, J., additional, A, A. L.-V., additional, Grill, J., additional, Puget, S., additional, Sainte-Rose, C., additional, Dufour, C., additional, Kieffer, V., additional, Dellatolas, G., additional, -Shkedi, E. B., additional, Ben Arush, M. W., additional, Kaplinsky, H., additional, Ash, S., additional, Goshen, Y., additional, Yaniv, I., additional, Cohen, I. J., additional, Levy, J. M., additional, Tello, T., additional, Lu, X., additional, Gao, D., additional, Wilkening, G., additional, Donson, A., additional, Foreman, N., additional, Liu, A., additional, Korzeniewska, J., additional, Baginska, B. D., additional, Perek, D., additional, Staccioli, S., additional, Chieffo, D., additional, Petrarca, M., additional, Moxon-Emre, I., additional, Taylor, M., additional, Bouffet, E., additional, Malkin, D., additional, Hawkins, C., additional, Scantlebury, N., additional, Mabbott, D., additional, Cunningham, T., additional, Piscione, J., additional, Igoe, D., additional, Orfus, M., additional, Bartels, U., additional, Laughlin, S., additional, Tabori, U., additional, Hardy, K., additional, Carlson-Green, B., additional, Conklin, H., additional, Dockstader, C., additional, Wang, F., additional, Bostan, S., additional, Liu, F., additional, Zou, P., additional, Conklin, H. M., additional, Mulhern, R. K., additional, Butler, R. W., additional, Ogg, R. J., additional, Diver, T., additional, Manley, P., additional, Kieran, M., additional, Chordas, C., additional, Liptak, C., additional, Delaney, B., additional, Brand, S., additional, and Rey-Casserly, C., additional
- Published
- 2012
- Full Text
- View/download PDF
54. Impairment of sexual activity before and after endoscopic totally extraperitoneal (TEP) hernia repair
- Author
-
Schouten, N., primary, van Dalen, T., additional, Smakman, N., additional, Clevers, G. J., additional, Davids, P. H. P., additional, Verleisdonk, E. J. M. M., additional, Tekatli, H., additional, and Burgmans, J. P. J., additional
- Published
- 2011
- Full Text
- View/download PDF
55. Expression of cocoa butter from cocoa nibs
- Author
-
Venter, M.J., primary, Schouten, N., additional, Hink, R., additional, Kuipers, N.J.M., additional, and de Haan, A.B., additional
- Published
- 2007
- Full Text
- View/download PDF
56. Ultra-fast LIGBTs and superjunction devices in membrane technology.
- Author
-
Udrea, F., Trajkovic, T., Lee, C., Garner, D., Yuan, X., Joyce, J., Udugampola, N., Bonnet, G., Coulson, D., Jacques, R., Izmajlowicz, M., van der Duijn Schouten, N., Ansari, Z., Moyse, P., and Amaratunga, G.A.J.
- Published
- 2005
- Full Text
- View/download PDF
57. 174 RELATIONSHIP BETWEEN METHANE AND HYDROGEN PRODUCTION IN AN ANAEROBIC FAECAL INCUBATION SYSTEM
- Author
-
Douwes, A C, primary, Van Der Burg, G J, additional, Schouten, N, additional, and Kneepkens, C M F, additional
- Published
- 1986
- Full Text
- View/download PDF
58. Invasion of superbugs: Cockroach-driven outbreak of multidrug-resistant Enterobacter in an ICU.
- Author
-
Hanrahan J, Schouten N, Fyffe SH, Jencson A, and Stroever S
- Abstract
Objective: To describe factors in an outbreak of multidrug-resistant Enterobacter cloacae (MRE) in an intensive care unit (ICU) over a 20-month period including the likely contribution of cockroaches to the outbreak., Design: This is a retrospective descriptive study., Setting: ICU in an urban hospital., Patients: All patients admitted to the ICU during the 20-month outbreak period were included in the study., Interventions: Infection prevention interventions included contact isolation, hand hygiene, dedicated patient equipment, environmental cultures, and pest control., Results: 25 patients were identified as being colonized or infected with MRE. Relatedness of the outbreak strain and strains found in cockroaches was demonstrated by pulse field gel electrophoresis. Standard IP interventions did not have an impact on the outbreak until pest control was added. Once additional pest control measures were put in place, the outbreak ended., Conclusions: Insects have a potential role in transmission of pathogens in hospitals and their role should be considered when outbreaks are being investigated., Competing Interests: There are no conflicting interests pertaining to this project.There are no declarations to be made regarding this study., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
59. Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.
- Author
-
Baboudjian M, Hashim H, Bhatt N, Creta M, De Nunzio C, Gacci M, Herrmann T, Karavitakis M, Malde S, Moris L, Netsch C, Rieken M, Sakalis V, Schouten N, Tutolo M, and Cornu JN
- Subjects
- Humans, Male, Europe, Urodynamics, Lower Urinary Tract Symptoms therapy, Lower Urinary Tract Symptoms diagnosis, Lower Urinary Tract Symptoms physiopathology, Lower Urinary Tract Symptoms etiology, Practice Guidelines as Topic, Urinary Bladder, Underactive diagnosis, Urinary Bladder, Underactive etiology, Urinary Bladder, Underactive physiopathology, Urinary Bladder, Underactive therapy, Urology standards
- Abstract
Background and Objective: The European Association of Urology (EAU) Guidelines Panel on non-neurogenic male lower urinary tract symptoms (LUTS) aimed to develop a new subchapter on underactive bladder (UAB) in non-neurogenic men to inform health care providers of current best evidence and practice. Here, we present a summary of the UAB subchapter that is incorporated into the 2024 version of the EAU guidelines on non-neurogenic male LUTS., Methods: A systematic literature search was conducted from 2002 to 2022, and articles with the highest certainty evidence were selected. A strength rating has been provided for each recommendation according to the EAU Guideline Office methodology., Key Findings and Limitations: Detrusor underactivity (DU) is a urodynamic diagnosis defined as a contraction of reduced strength and/or duration, resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span. UAB is a terminology that should be reserved for describing symptoms and clinical features related to DU. Invasive urodynamics is the only widely accepted method for diagnosing DU. In patients with persistently elevated postvoid residual (ie, >300 ml), intermittent catheterization is indicated and preferred to indwelling catheters. Alpha-adrenergic blockers are recommended before more invasive techniques, but the level of evidence is low. In men with DU and concomitant benign prostatic obstruction (BPO), benign prostatic surgery should be considered only after appropriate counseling. In men with DU and no BPO, a test phase of sacral neuromodulation may be considered., Conclusions and Clinical Implications: The current text represents a summary of the new subchapter on UAB. For more detailed information, refer to the full-text version available on the EAU website (https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts)., (Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
60. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
- Author
-
O'Hare P, Cooney T, de Blank P, Gutmann DH, Kieran M, Milde T, Fangusaro J, Fisher M, Avula S, Packer R, Fukuoka K, Mankad K, Mueller S, Waanders AJ, Opocher E, Bouffet E, Raabe E, Werle NE, Azizi AA, Robison NJ, Hernáiz Driever P, Russo M, Schouten N, van Tilburg CM, Sehested A, Grill J, Bandopadhayay P, Kilday JP, Witt O, Ashley DM, Ertl-Wagner BB, Tabori U, and Hargrave DR
- Subjects
- Humans, Child, Protein Kinase Inhibitors therapeutic use, Neoplasm Grading, Glioma drug therapy, Glioma pathology, Brain Neoplasms drug therapy, Brain Neoplasms pathology, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local pathology, Drug Resistance, Neoplasm, Consensus, Delphi Technique
- Abstract
Pediatric low-grade glioma (pLGG) is the most common childhood brain tumor group. The natural history, when curative resection is not possible, is one of a chronic disease with periods of tumor stability and episodes of tumor progression. While there is a high overall survival rate, many patients experience significant and potentially lifelong morbidities. The majority of pLGGs have an underlying activation of the RAS/MAPK pathway due to mutational events, leading to the use of molecularly targeted therapies in clinical trials, with recent regulatory approval for the combination of BRAF and MEK inhibition for BRAFV600E mutated pLGG. Despite encouraging activity, tumor regrowth can occur during therapy due to drug resistance, off treatment as tumor recurrence, or as reported in some patients as a rapid rebound growth within 3 months of discontinuing targeted therapy. Definitions of these patterns of regrowth have not been well described in pLGG. For this reason, the International Pediatric Low-Grade Glioma Coalition, a global group of physicians and scientists, formed the Resistance, Rebound, and Recurrence (R3) working group to study resistance, rebound, and recurrence. A modified Delphi approach was undertaken to produce consensus-based definitions and recommendations for regrowth patterns in pLGG with specific reference to targeted therapies., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
61. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
- Author
-
Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, Gandaglia G, Gillessen S, Grivas N, Henry AM, Lardas M, J L H van Leenders G, Liew M, Linares Espinos E, Oldenburg J, van Oort IM, Oprea-Lager DE, Ploussard G, Roberts MJ, Rouvière O, Schoots IG, Schouten N, Smith EJ, Stranne J, Wiegel T, Willemse PM, and Cornford P
- Subjects
- Humans, Male, Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant pathology, Prostatic Neoplasms, Castration-Resistant therapy, Prostatic Neoplasms, Castration-Resistant drug therapy, Neoplasm Recurrence, Local, Prostatic Neoplasms pathology, Prostatic Neoplasms therapy
- Abstract
Background and Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines on the treatment of relapsing, metastatic, and castration-resistant prostate cancer (PCa) have been updated. Here we provide a summary of the 2024 guidelines., Methods: The panel performed a literature review of new data, covering the time frame between 2020 and 2023. The guidelines were updated and a strength rating for each recommendation was added on the basis of a systematic review of the evidence., Key Findings and Limitations: Risk stratification for relapsing PCa after primary therapy may guide salvage therapy decisions. New treatment options, such as androgen receptor-targeted agents (ARTAs), ARTA + chemotherapy combinations, PARP inhibitors and their combinations, and prostate-specific membrane antigen-based therapy have become available for men with metastatic PCa., Conclusions and Clinical Implications: Evidence for relapsing, metastatic, and castration-resistant PCa is evolving rapidly. These guidelines reflect the multidisciplinary nature of PCa management. The full version is available online (http://uroweb.org/guideline/ prostate-cancer/)., Patient Summary: This article summarises the 2024 guidelines for the treatment of relapsing, metastatic, and castration-resistant prostate cancer. These guidelines are based on evidence and guide doctors in discussing treatment decisions with their patients. The guidelines are updated every year., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
62. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
- Author
-
Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, Eberli D, De Meerleer G, De Santis M, Farolfi A, Gandaglia G, Gillessen S, Grivas N, Henry AM, Lardas M, van Leenders GJLH, Liew M, Linares Espinos E, Oldenburg J, van Oort IM, Oprea-Lager DE, Ploussard G, Roberts MJ, Rouvière O, Schoots IG, Schouten N, Smith EJ, Stranne J, Wiegel T, Willemse PM, and Tilki D
- Subjects
- Male, Humans, Early Detection of Cancer standards, Prostatic Neoplasms therapy, Prostatic Neoplasms pathology, Prostatic Neoplasms diagnosis
- Abstract
Background and Objective: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa., Methods: The panel performed a literature review of all new data published in English, covering the time frame between May 2020 and 2023. The guidelines were updated, and a strength rating for each recommendation was added based on a systematic review of the evidence., Key Findings and Limitations: A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50 yr of age and based on individualised life expectancy. The use of multiparametric magnetic resonance imaging in order to avoid unnecessary biopsies is recommended. When a biopsy is considered, a combination of targeted and regional biopsies should be performed. Prostate-specific membrane antigen positron emission tomography imaging is the most sensitive technique for identifying metastatic spread. Active surveillance is the appropriate management for men with low-risk PCa, as well as for selected favourable intermediate-risk patients with International Society of Urological Pathology grade group 2 lesions. Local therapies are addressed, as well as the management of persistent prostate-specific antigen after surgery. A recommendation to consider hypofractionation in intermediate-risk patients is provided. Patients with cN1 PCa should be offered a local treatment combined with long-term intensified hormonal treatment., Conclusions and Clinical Implications: The evidence in the field of diagnosis, staging, and treatment of localised PCa is evolving rapidly. These PCa guidelines reflect the multidisciplinary nature of PCa management., Patient Summary: This article is the summary of the guidelines for "curable" prostate cancer. Prostate cancer is "found" through a multistep risk-based screening process. The objective is to find as many men as possible with a curable cancer. Prostate cancer is curable if it resides in the prostate; it is then classified into low-, intermediary-, and high-risk localised and locally advanced prostate cancer. These risk classes are the basis of the treatments. Low-risk prostate cancer is treated with "active surveillance", a treatment with excellent prognosis. For low-intermediary-risk active surveillance should also be discussed as an option. In other cases, active treatments, surgery, or radiation treatment should be discussed along with the potential side effects to allow shared decision-making., (Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
63. Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology.
- Author
-
Sartori AM, Kessler TM, Castro-Díaz DM, de Keijzer P, Del Popolo G, Ecclestone H, Frings D, Groen J, Hamid R, Karsenty G, Musco S, Padilla-Fernández B, Pannek J, Schouten N, van der Vorm A, and Blok BFM
- Subjects
- Humans, Europe, Urologic Diseases therapy, Urologic Diseases diagnosis, Societies, Medical, Nervous System Diseases therapy, Nervous System Diseases diagnosis, Urology standards, Practice Guidelines as Topic
- Abstract
Background and Objective: Most patients with neurourological disorders require lifelong medical care. The European Association of Urology (EAU) regularly updates guidelines for diagnosis and treatment of these patients. The objective of this review is to provide a summary of the 2024 updated EAU guidelines on neurourology., Methods: A structured literature review covering the timeframe 2021-2023 was conducted for the guideline update. A level of evidence and a strength rating were assigned for each recommendation on the basis of the literature data., Key Findings and Limitations: Neurological conditions significantly affect urinary, sexual, and bowel function, and lifelong management is required for neurourological patients to maintain their quality of life and prevent urinary tract deterioration. Early diagnosis and effective treatment are key, and comprehensive clinical assessments, including urodynamics, are crucial. Management should be customised to individual needs and should involve a multidisciplinary approach and address sexuality and fertility. Lifelong monitoring and follow-up highlight the importance of continuous care for neurourological patients., Conclusions and Clinical Implications: The 2024 EAU guidelines on neurourology provide an up-to-date overview of available evidence on diagnosis, treatment, and follow-up for neurourological patients., Patient Summary: Neurological disorders very frequently affect the lower urinary tract and sexual and bowel function and patients need lifelong management. We summarise the updated European Association of Urology guidelines on neurourology to provide patients and caregivers with the latest insights for optimal health care support., (Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
64. Summary Paper of the Updated 2023 European Association of Urology Guidelines on Urological Trauma.
- Author
-
Serafetinidis E, Campos-Juanatey F, Hallscheidt P, Mahmud H, Mayer E, Schouten N, Sharma DM, Waterloos M, Zimmermann K, and Kitrey ND
- Subjects
- Humans, Europe, Societies, Medical, Urinary Tract injuries, Wounds and Injuries therapy, Urology, Practice Guidelines as Topic
- Abstract
Context: The European Association of Urology (EAU) Guidelines Panel for Urological Trauma has produced guidelines in order to assist medical professionals in the management of urological trauma in adults for the past 20 yr. It must be emphasised that clinical guidelines present the best evidence available to the experts, but following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients regarding other parameters such as experience and available facilities. Guidelines are not mandates and do not purport to be a legal standard of care., Objective: To present a summary of the 2023 version of the EAU guidelines on the management of urological trauma., Evidence Acquisition: A systematic literature search was conducted from 1966 to 2022, and articles with the highest certainty evidence were selected. It is important to note that due to its nature, genitourinary trauma literature still relies heavily on expert opinion and retrospective series., Evidence Synthesis: Databases searched included Medline, EMBASE, and the Cochrane Libraries, covering a time frame between May 1, 2021 and April 29, 2022. A total of 1236 unique records were identified, retrieved, and screened for relevance., Conclusions: The guidelines provide an evidence-based approach for the management of urological trauma., Patient Summary: Trauma is a serious public health problem with significant social and economic costs. Urological trauma is common; traffic accidents, falls, intrapersonal violence, and iatrogenic injuries are the main causes. Developments in technology, continuous training of medical professionals, and improved care of polytrauma patients reduce morbidity and maximise the opportunity for quick recovery., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
65. From BPH to male LUTS: a 20-year journey of the EAU guidelines.
- Author
-
Gravas S, Malde S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Karavitakis M, Mamoulakis C, Rieken M, Sakalis VI, Schouten N, Smith EJ, Speakman MJ, Tikkinen KAO, Alivizatos G, Bach T, Bachmann A, Descazeaud A, Desgrandchamps F, Drake M, Emberton M, Kyriazis I, Madersbacher S, Michel MC, N'Dow J, Perachino M, Plass K, Rioja Sanz C, Umbach R, de Wildt M, Oelke M, and de la Rosette JJMCH
- Subjects
- Humans, Male, Prostatic Neoplasms, Prostatic Hyperplasia complications, Prostatic Hyperplasia diagnosis, Prostatic Hyperplasia epidemiology, Lower Urinary Tract Symptoms diagnosis, Lower Urinary Tract Symptoms epidemiology, Lower Urinary Tract Symptoms etiology
- Published
- 2024
- Full Text
- View/download PDF
66. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.
- Author
-
Gravas S, Gacci M, Gratzke C, Herrmann TRW, Karavitakis M, Kyriazis I, Malde S, Mamoulakis C, Rieken M, Sakalis VI, Schouten N, Speakman MJ, Tikkinen KAO, and Cornu JN
- Subjects
- Humans, Male, Urinalysis adverse effects, Urology, Lower Urinary Tract Symptoms diagnosis, Lower Urinary Tract Symptoms etiology, Lower Urinary Tract Symptoms therapy, Nocturia, Prostatic Neoplasms complications, Prostatic Hyperplasia complications, Prostatic Hyperplasia diagnosis, Prostatic Hyperplasia therapy
- Abstract
Context: Lower urinary tract symptoms (LUTS) are common, often bothersome, and have multifactorial aetiology., Objective: To present a summary of the 2023 version of the European Association of Urology guidelines on the management of male LUTS., Evidence Acquisition: A structured literature search from 1966 to 2021 selected the articles with the highest certainty evidence. The Delphi technique consensus approach was used to develop the recommendations., Evidence Synthesis: The assessment of men with LUTS should be practical. A careful medical history and physical examination are essential. Validated symptom scores, urine test, uroflowmetry, and postvoid urine residual, as well as frequency-volume charts for patients with nocturia or predominately storage symptoms should be used. Prostate-specific antigen should be ordered if a diagnosis of prostate cancer changes the treatment plan. Urodynamics should be performed for selected patients. Men with mild symptoms are candidates for watchful waiting. Behavioural modification should be offered to men with LUTS prior to, or concurrent with, treatment. The choice of medical treatment depends on the assessment findings, predominant type of symptoms, ability of the treatment to change the findings, and the expectations to be met in terms of the speed of onset, efficacy, side effects, and disease progression. Surgery is reserved for men with absolute indications, and for patients who fail or prefer not to receive medical therapy. Surgical management has been divided into five sections: resection, enucleation, vaporisation, and alternative ablative and nonablative techniques. The choice of surgical technique depends on patient's characteristics, expectations, and preferences; surgeon's expertise; and availability of modalities., Conclusions: The guidelines provide an evidence-based approach for the management of male LUTS., Patient Summary: A clinical assessment should identify the cause(s) of symptoms and define the clinical profile and patient's expectations. The treatment should aim to ameliorate symptoms and reduce the risk of complications., (Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
67. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.
- Author
-
MacLennan S, Azevedo N, Duncan E, Dunsmore J, Fullwood L, Lumen N, Plass K, Ribal MJ, Roobol MJ, Nieboer D, Schouten N, Skolarus TA, Smith EJ, N'Dow J, Mottet N, and Briganti A
- Subjects
- Male, Humans, Androgen Antagonists adverse effects, Androgens therapeutic use, Cross-Sectional Studies, Retrospective Studies, Europe, Hospitals, Prostatic Neoplasms drug therapy, Prostatic Neoplasms surgery, Urology
- Abstract
Background: Evidence-practice gaps exist in urology. We previously surveyed European Association of Urology (EAU) guidelines for strong recommendations underpinned by high-certainty evidence that impact patient experience for which practice variations were suspected. The recommendation "Do not offer neoadjuvant androgen deprivation therapy (ADT) before surgery for patients with prostate cancer" was prioritised for further investigation. ADT before surgery is neither clinically effective nor cost effective and has serious side effects. The first step in improving implementation problems is to understand their extent. A clear picture of practice regarding ADT before surgery across Europe is not available., Objective: To assess current ADT use before prostate cancer surgery in Europe., Design, Setting, and Participants: This was an observational cross-sectional study. We retrospectively audited recent ADT practices in a multicentre international setting. We used nonprobability purposive sampling, aiming for breadth in terms of low- versus high-volume, academic, versus community and public versus private centres., Outcome Measurements and Statistical Analysis: Our primary outcome was adherence to the ADT recommendation. Descriptive statistics and a multilevel model were used to investigate differences between countries across different factors (volume, centre type, and funding type). Subgroup analyses were performed for patients with low, intermediate, and high risk, and for those with locally advanced prostate cancer. We also collected reasons for nonadherence., Results and Limitations: We included 6598 patients with prostate cancer from 187 hospitals in 31 countries from January 1, 2017 to May 1, 2020. Overall, nonadherence was 2%, (range 0-32%). Most of the variability was found in the high-risk subgroup, for which nonadherence was 4% (range 0-43%). Reasons for nonadherence included attempts to improve oncological outcomes or preoperative tumour parameters; attempts to control the cancer because of long waiting lists; and patient preference (changing one's mind from radiotherapy to surgery after neoadjuvant ADT had commenced or feeling that the side effects were intolerable). Although we purposively sampled for variety within countries (public/private, academic/community, high/low-volume), a selection bias toward centres with awareness of guidelines is possible, so adherence rates may be overestimated., Conclusions: EAU guidelines recommend against ADT use before prostate cancer surgery, yet some guideline-discordant ADT use remains at the cost of patient experience and an additional payer and provider burden. Strategies towards discontinuation of inappropriate preoperative ADT use should be pursued., Patient Summary: Androgen deprivation therapy (ADT) is sometimes used in men with prostate cancer who will not benefit from it. ADT causes side effects such as weight gain and emotional changes and increases the risk of cardiovascular disease, diabetes, and osteoporosis. Guidelines strongly recommend that men opting for surgery should not receive ADT, but it is unclear how well the guidance is followed. We asked urologists across Europe how patients in their institutions were treated over the past few years. Most do not use ADT before surgery, but this still happens in some places. More research is needed to help doctors to stop using ADT in patients who will not benefit from it., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
68. Prospective observational cohort study of reached protein and energy targets in general wards during the post-intensive care period: The PROSPECT-I study.
- Author
-
Slingerland-Boot R, van der Heijden I, Schouten N, Driessen L, Meijer S, Mensink M, and van Zanten A
- Subjects
- Cohort Studies, Critical Care methods, Critical Illness therapy, Energy Intake, Humans, Intensive Care Units, Length of Stay, Prospective Studies, Dietary Proteins, Patients' Rooms
- Abstract
Introduction: Nutrition plays an essential role in the recovery of critical illness. In the post-Intensive Care Unit (ICU) period, patients typically return to oral nutrition gradually. However, studies quantifying nutritional intake in the post-ICU hospitalization period are scarce and formal guidelines are lacking. This study aims to describe energy and protein intake in detail over the entire post-ICU hospitalization period and explore associations between protein intake and clinical outcomes., Methods: A prospective observational single-center cohort study was conducted amongst post-ICU patients in general wards after a minimum ICU-stay of 72 h and who received (par)enteral feeding for ≥24 h in the ICU. Oral intake was assessed daily using food order lines and digital photography of meal leftovers. Other data, including amounts of (par)enteral nutrition, were collected from electronic medical records. The primary outcome was to identify energy and protein intake, and reached targets, in the post-ICU period. In addition, length of hospital stay after ICU discharge, readmission and mortality rates were compared between patients meeting protein targets or not., Results: In total, 48 patients were included. Complete nutritional data of 34 patients were analyzed in the current study, adding up to a total number of 484 observational days, 1681 photos and 6634 food order lines. Inter-rater agreement was excellent (ICC 0.878). Overall mean energy and protein adequacy for all nutritional groups was 82.3% (SD 18.3) and 83.1% (SD 19.8). Only 51.2% of the study participants (n = 21) reached overall >90% of prescribed protein targets during their entire post-ICU ward stay. The lowest intake was seen in the patient group with exclusively oral intake (median protein adequacy 75.5%), whereas patients with (supplemental) enteral nutrition (EN) all met >90% of their protein targets. Prescribed targets were below recommendations, and prescribed calories and proteins were neither ordered nor consumed. Discontinuation of EN resulted in immediate marked drops in energy (44.1%) and protein intake (50.7%). Subsequently, patients needed up to six days to reach protein targets again. No differences in clinical outcomes were observed., Conclusion: Most patients did not meet energy and protein targets in the post-ICU hospitalization period. Nutrition performance was highly dependent on the route of nutrition and was lowest among patients with oral intake only (despite of food fortification strategies and/or oral nutritional supplements). The best intake was observed in patients receiving (supplemental) EN. However, cessation of EN posed an immediate nutritional risk. No differences in clinical outcomes were found in this study. Our findings stress the need for follow-up studies to close the gap with individualized nutritional support in the post-ICU period to reach protein and energy targets., Competing Interests: Conflict of interest Prof. Dr A.R.H. van Zanten reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from Baxter, Braun, Cardinal Health, Danone-Nutricia, Dim-3, Fresenius Kabi, Mermaid, Lyric, and Nestle-Novartis. The other authors have nothing to declare., (Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
69. European Association of Urology Guidelines on Male Urinary Incontinence.
- Author
-
Gacci M, Sakalis VI, Karavitakis M, Cornu JN, Gratzke C, Herrmann TRW, Kyriazis I, Malde S, Mamoulakis C, Rieken M, Schouten N, Smith EJ, Speakman MJ, Tikkinen KAO, and Gravas S
- Subjects
- Aged, Humans, Male, Quality of Life, Urinary Incontinence, Urge diagnosis, Urinary Incontinence, Urge therapy, Urinary Incontinence diagnosis, Urinary Incontinence therapy, Urinary Incontinence, Stress diagnosis, Urinary Incontinence, Stress therapy, Urology
- Abstract
Context: Urinary incontinence (UI) is a common condition in elderly men causing a severe worsening of quality of life, and a significant cost for both patients and health systems., Objective: To report a practical, evidence-based, guideline on definitions, pathophysiology, diagnostic workup, and treatment options for men with different forms of UI., Evidence Acquisition: A comprehensive literature search, limited to studies representing high levels of evidence and published in the English language, was performed. Databases searched included Medline, EMBASE, and the Cochrane Libraries. A level of evidence and a grade of recommendation were assigned., Evidence Synthesis: UI can be classified into stress urinary incontinence (SUI), urge urinary incontinence (UUI), and mixed urinary incontinence. A detailed description of the pathophysiology and diagnostic workup has been reported. Simple clinical interventions, behavioural and physical modifications, and pharmacological treatments comprise the initial management for all kinds of UI. Surgery for SUI includes bulking agents, male sling, and compression devices. Surgery for UUI includes bladder wall injection of botulinum toxin A, sacral nerve stimulation, and cystoplasty/urinary diversion., Conclusions: This 2022 European Association of Urology guideline summary provides updated information on definition, pathophysiology, diagnosis, and treatment of male UI., Patient Summary: Male urinary incontinence comprises a broad subject area, much of which has been covered for the first time in the literature in a single manuscript. The European Association of Urology Non-neurogenic Male Lower Urinary Tract Symptoms Guideline Panel has released this new guidance, with the aim to provide updated information for urologists to be able to follow diagnostic and therapeutic indications for optimising patient care., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
70. Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis.
- Author
-
Verwoerd A, Armbrust W, Cowan K, van den Berg L, de Boer J, Bookelman S, Britstra M, Cappon J, Certan M, Dedding C, van den Haspel K, Muller PH, Jongsma K, Lelieveld O, van Loosdregt J, Olsder W, Rocha J, Schatorjé E, Schouten N, Swart JF, Vastert S, Walter M, and Schoemaker CG
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Humans, Middle Aged, Netherlands, Self Report, Young Adult, Arthritis, Juvenile therapy, Caregivers, Health Personnel
- Abstract
Background: Involving the end-users of scientific research (patients, carers and clinicians) in setting research priorities is important to formulate research questions that truly make a difference and are in tune with the needs of patients. We therefore aimed to generate a national research agenda for Juvenile Idiopathic Arthritis (JIA) together with patients, their caregivers and healthcare professionals through conducting a nationwide survey among these stakeholders., Methods: The James Lind Alliance method was used, tailored with additional focus groups held to involve younger patients. First, research questions were gathered through an online and hardcopy survey. The received questions that were in scope were summarised and a literature search was performed to verify that questions were unanswered. Questions were ranked in the interim survey, and the final top 10 was chosen during a prioritisation workshop., Results: Two hundred and seventy-eight respondents submitted 604 questions, of which 519 were in scope. Of these 604 questions, 81 were generated in the focus groups with younger children. The questions were summarised into 53 summary questions. An evidence checking process verified that all questions were unanswered. A total of 303 respondents prioritised the questions in the interim survey. Focus groups with children generated a top 5 of their most important questions. Combining this top 5 with the top 10s of patients, carers, and clinicians led to a top 21. Out of these, the top 10 research priorities were chosen during a final workshop. Research into pain and fatigue, personalised treatment strategies and aetiology were ranked high in the Top 10., Conclusions: Through this study, the top 10 research priorities for JIA of patients, their caregivers and clinicians were identified to inform researchers and research funders of the research topics that matter most to them. The top priority involves the treatment and mechanisms behind persisting pain and fatigue when the disease is in remission.
- Published
- 2021
- Full Text
- View/download PDF
71. Higher Recurrence Rate After Endoscopic Totally Extraperitoneal (TEP) Inguinal Hernia Repair With Ultrapro Lightweight Mesh: 5-Year Results of a Randomized Controlled Trial (TULP-trial).
- Author
-
Roos MM, Bakker WJ, Schouten N, Voorbrood CEH, Clevers GJ, Verleisdonk EJ, Davids PH, and Burgmans JP
- Subjects
- Adult, Aged, Double-Blind Method, Follow-Up Studies, Herniorrhaphy methods, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Polypropylenes, Recurrence, Treatment Outcome, Hernia, Inguinal surgery, Herniorrhaphy instrumentation, Laparoscopy, Surgical Mesh
- Abstract
Objective: The aim of this study was to determine inguinal hernia recurrence rates 5 years after endoscopic totally extraperitoneal (TEP) inguinal hernia repair when either lightweight or heavyweight mesh was used., Background: Recurrence is an important complication of inguinal hernia surgery. Higher recurrence rates of Ultrapro lightweight meshes after TEP repair have been demonstrated, yet data regarding long-term follow-up are limited., Methods: From 2010 to 2012, 950 male adult patients with primary unilateral hernias were randomized to TEP hernia repair with heavyweight (Prolene) or lightweight (Ultrapro) mesh. Five years postoperatively, the validated PINQ-PHONE telephone questionnaire was carried out. Participants with a positive questionnaire reply were scheduled for a clinical visit. A recurrence was defined as a clinically detectable bulge in the operated groin on physical examination., Results: Data on development of recurrence could be obtained from 790 patients (83.2% 5-year follow-up rate). Four patients presented with a recurrence at the outpatient clinic between 2 and 5 years postoperatively. Thirty-five patients (4.6%) with a positive PINQ-PHONE reply (60.0% lightweight vs 40.0% heavyweight) were physically examined at the outpatient clinic. In 2 patients (lightweight) a recurrence was detected. The total 5-year recurrence rate after TEP hernia repair was 2.4% (3.8% lightweight, 1.1% heavyweight, P = 0.01). A significantly higher recurrence rate for lightweight mesh in primary direct hernias was found (P = 0.003)., Conclusions: The overall recurrence rate 5 years after TEP repair was low. Ultrapro lightweight meshes showed higher recurrence rates than heavyweight meshes and are not recommended for endoscopic TEP inguinal hernia repair.
- Published
- 2018
- Full Text
- View/download PDF
72. Long-term Results of a Randomized Double-blinded Prospective Trial of a Lightweight (Ultrapro) Versus a Heavyweight Mesh (Prolene) in Laparoscopic Total Extraperitoneal Inguinal Hernia Repair (TULP-trial).
- Author
-
Burgmans JP, Voorbrood CE, Simmermacher RK, Schouten N, Smakman N, Clevers G, Davids PH, Verleisdonk EM, Hamaker ME, Lange JF, and van Dalen T
- Subjects
- Adult, Aged, Aged, 80 and over, Double-Blind Method, Humans, Male, Middle Aged, Pain Measurement, Pain, Postoperative prevention & control, Polypropylenes, Prospective Studies, Quality of Life, Recurrence, Treatment Outcome, Hernia, Inguinal surgery, Herniorrhaphy instrumentation, Laparoscopy, Surgical Mesh
- Abstract
Objective: The aim of the randomized clinical trial was to compare the 2 years of clinical outcomes of a lightweight (Ultrapro) vs a heavyweight (Prolene) mesh for laparoscopic total extraperitoneal (TEP) inguinal hernia repair., Background: Lightweight meshes reduce postoperative pain and stiffness in open anterior inguinal hernia repair. The discussion about a similar benefit for laparoscopic repair is ongoing, but concerns exist about higher recurrence rates., Methods: Between March 2010 and October 2012, male patients who presented with a primary, reducible unilateral inguinal hernia who underwent day-case TEP repair were eligible. Outcome parameters included chronic pain, recurrence, foreign body feeling, and quality of life scores., Results: During the study period, 950 patients were included. One year postoperatively the presence of relevant pain (Numeric Rating Score 4-10) was significantly higher in the lightweight mesh group (2.9%) compared with the heavyweight mesh group (0.7%) (P = 0.01), and after 2 years this difference remained significant (P = 0.03). There were 4 (0.8%) recurrent hernias in the heavyweight mesh group and 13 (2.7%) in the lightweight group (P = 0.03). No differences in foreign body feeling or quality of life scores were detected., Conclusions: In TEP hernia surgery, there was no benefit of lightweight over heavyweight meshes observed 2 years postoperatively.
- Published
- 2016
- Full Text
- View/download PDF
73. Mechanism, assessment, and incidence of male infertility after inguinal hernia surgery: a review of the preclinical and clinical literature.
- Author
-
Tekatli H, Schouten N, van Dalen T, Burgmans I, and Smakman N
- Subjects
- Animals, Hernia, Inguinal complications, Hernia, Inguinal physiopathology, Herniorrhaphy methods, Humans, Incidence, Infertility, Male pathology, Ischemia etiology, Male, Models, Animal, Orchitis etiology, Pain etiology, Spermatic Cord blood supply, Spermatic Cord injuries, Spermatic Cord physiopathology, Testis blood supply, Testis injuries, Testis physiopathology, Vas Deferens injuries, Vas Deferens physiopathology, Hernia, Inguinal surgery, Herniorrhaphy adverse effects, Infertility, Male etiology, Infertility, Male physiopathology, Surgical Mesh
- Abstract
Background: The treatment of inguinal hernia has changed considerably over the past 15 years. We reviewed the preclinical and clinical literature to find out the effect of inguinal hernia surgery on male fertility because it has been suggested that hernia surgery may impair testicular function and male fertility., Data Sources: A search on Embase, MEDLINE, and the Cochrane Library was performed to find related articles., Conclusions: Animal models show substantial effects of hernia repair on the structures in the spermatic cord, which is more pronounced in mesh repairs. Although the number of studies and the included numbers of patients were limited, clinical studies indicate that these potential adverse effects do not seem to have a clinical impact on male fertility in humans with inguinal hernias. Future clinical studies, preferably with bilateral patients, are necessary to investigate the clinical relevance of the effects of inguinal hernia and hernia surgery on male fertility., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
74. The effect of ultrapro or prolene mesh on postoperative pain and well-being following endoscopic Totally Extraperitoneal (TEP) hernia repair (TULP): study protocol for a randomized controlled trial.
- Author
-
Schouten N, van Dalen T, Smakman N, Elias SG, Clevers GJ, Verleisdonk EJ, Davids PH, and Burgmans IP
- Subjects
- Adult, Double-Blind Method, Equipment Design, Hernia, Inguinal psychology, Humans, Male, Netherlands, Pain Measurement, Pain, Postoperative diagnosis, Pain, Postoperative etiology, Pain, Postoperative psychology, Patient Satisfaction, Patient Selection, Prospective Studies, Recurrence, Severity of Illness Index, Surveys and Questionnaires, Time Factors, Treatment Outcome, Endoscopy adverse effects, Endoscopy instrumentation, Hernia, Inguinal surgery, Herniorrhaphy adverse effects, Herniorrhaphy instrumentation, Herniorrhaphy methods, Pain, Postoperative prevention & control, Polypropylenes, Quality of Life, Research Design, Surgical Mesh
- Abstract
Background: The purpose of this study was to describe the rationale and design of a randomized controlled trial analyzing the effects of mesh type (Ultrapro versus Prolene mesh) on postoperative pain and well-being following an endoscopic Totally Extraperitoneal (TEP) repair for inguinal hernias (short: TULP trial)., Methods and Design: The TULP trial is a prospective, two arm, double blind, randomized controlled trial to assess chronic postoperative pain and quality of life following implantation of a lightweight (Ultrapro) and heavyweight (Prolene) mesh in endoscopic TEP hernia repair. The setting is a high-volume single center hospital, specializing in TEP hernia repair. All patients are operated on by one of four surgeons. Adult male patients (≥18 years of age) with primary, reducible, unilateral inguinal hernias and no contraindications for TEP repair are eligible for inclusion in the study. The primary outcome is substantial chronic postoperative pain, defined as moderate to severe pain persisting ≥ 3 months postoperatively (Numerical Rating Scale, NRS 4-10). Secondary endpoints are the individual development of pain until three years after the TEP procedure, the quality of life (QoL), recurrence rate, patient satisfaction and complications., Discussion: Large prospective randomized controlled studies with a long follow-up evaluating the incidence of chronic postoperative pain following implantation of lightweight and heavyweight mesh in endoscopic (TEP) hernia repair are limited. By studying the presence of pain and quality of life, but also complications and recurrences in a large patient population, a complete efficiency and feasibility assessment of both mesh types in TEP hernia repair will be performed., Trial Registration: The TULP study is registered in the Dutch Trial Register (NTR2131).
- Published
- 2012
- Full Text
- View/download PDF
75. Male infertility after endoscopic Totally Extraperitoneal (Tep) hernia repair (Main): rationale and design of a prospective observational cohort study.
- Author
-
Schouten N, van Dalen T, Smakman N, Elias SG, van de Water C, Spermon RJ, Mulder LS, and Burgmans IP
- Subjects
- Adolescent, Adult, Herniorrhaphy methods, Humans, Male, Middle Aged, Young Adult, Endoscopy, Hernia, Inguinal surgery, Herniorrhaphy adverse effects, Infertility, Male etiology, Surgical Mesh
- Abstract
Background: To describe the rationale and design of an observational cohort study analyzing the effects of endoscopic Totally Extraperitoneal (TEP) hernia repair on male fertility (MAIN study)., Methods and Design: The MAIN study is an observational cohort study designed to assess fertility after endoscopic TEP hernia repair. The setting is a high-volume single center hospital, specialized in TEP hernia repair. Male patients of 18-60 years of age, with primary, reducible, bilateral inguinal hernias and no contraindications for endoscopic TEP repair are eligible for inclusion in this study. Patients with an ASA-classification≥III and patients with recurrent and/or scrotal hernias and/or a medical history of pelvic surgery and/or radiotherapy, known fertility problems, diabetes and/or other diseases associated with a risk of fertility problems, will be excluded. The primary outcome is the testicular perfusion before and 6 months after TEP hernia repair (assessed by means of a scrotal ultrasonography). Secondary endpoints are the testicular volume (Ultrasound), semen quality and quantity and the endocrinological status, based on serum levels of the sexual hormones follicle-stimulating hormone (FSH), luteinizing hormone (LSH), testosterone and inhibin B before and 6 months after TEP hernia repair., Discussion: The use of polypropylene mesh is associated with a strong foreign body reaction which could play a role in chronic groin pain development. Since the mesh in (endoscopic) inguinal hernia repair is placed in close contact to the vas deferens and spermatic vessels, the mesh-induced inflammatory reaction could lead to a dysfunction of these structures. Relevant large and prospective clinical studies on the problem are limited. This study will provide a complete assessment of fertility in male patients who undergo simultaneous bilateral endoscopic TEP hernia repair, by analyzing testicular perfusion and volume, semen quantity and quality and endocrinological status before and 6 months after TEP repair., Trial Registration: The MAIN study is registered in the Dutch Trial Register (NTR2208).
- Published
- 2012
- Full Text
- View/download PDF
76. Temporary end ileostomy with subcutaneously buried efferent limb: results and potential advantages.
- Author
-
van der Sluis FF, Schouten N, de Graaf PW, Karsten TM, and Stassen LP
- Subjects
- Anastomotic Leak, Female, Hernia, Humans, Ileus, Male, Middle Aged, Skin Diseases, Surgical Wound Dehiscence, Treatment Outcome, Wound Infection, Ileostomy adverse effects, Ileostomy methods, Ileum surgery
- Abstract
Purpose: To evaluate the results of a modified technique of creating a defunctioning end ileostomy., Methods: Medical records of all consecutive patients with a defunctioning end ileostomy with buried efferent limb operated at our hospital between January 2000 and December 2007 were reviewed. The defunctioning end ileostomy with buried efferent limb is created by closing the distal limb and positioning it in the subcutis. Parameters studied were: stomal and reversal related complications., Results: 66 patients were included. Between construction and closure of the stoma, a total of 21 patients (31.8%) developed stoma-related complications. In 1 patient (1.5%) high output occurred, in 6 (9%) stomal retraction and in 4 (6.1%) a parastomal hernia occurred. Peristomal skin problems were observed in 14 patients (21.2%) in the early postoperative period, decreasing to 6 patients (9.1%) after 3 weeks. In 1 patient, stoma closure could not be performed through a local approach and formal laparotomy was necessary. Complications of loop ileostomy as reported in the literature show relatively high rates of peristomal skin and leakage problems., Conclusions: Our results suggest that end ileostomy with subcutaneous buried efferent limb offers advantages over loop ileostomy with regard to the risk of developing peristomal skin and leakage problems., (Copyright © 2010 S. Karger AG, Basel.)
- Published
- 2010
- Full Text
- View/download PDF
77. Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?
- Author
-
Parikova A, Struijk DG, Zweers MM, Langedijk M, Schouten N, van den Berg N, Duis S, and Krediet RT
- Subjects
- Adult, Biological Transport, Body Fluids metabolism, Chromatography, Liquid, Creatinine metabolism, Female, Glucose metabolism, Humans, Hydrogen-Ion Concentration, Immunoenzyme Techniques, Male, Middle Aged, Permeability, Proteins metabolism, Sodium metabolism, Ultrafiltration, Urea metabolism, Uric Acid metabolism, Dialysis Solutions chemistry, Peritoneal Dialysis, Peritoneum metabolism
- Abstract
Background: Peritoneal function tests are performed in peritoneal dialysis (PD) patients to characterize peritoneal membrane status. A low pH/high glucose degradation product (GDP) dialysis solution is used as the test solution. The objective of the present study was to compare a 3.86% glucose, low pH/high GDP dialysis solution (pH 5.5) with a 3.86% glucose, normal pH/low GDP dialysis solution (pH 7.4) in assessments of peritoneal membrane function., Methods: Two standard peritoneal permeability analyses (SPA) were performed in 10 stable PD patients within 2 weeks. One SPA was done with the 3.86% low pH/high GDP solution, and the other with the 3.86% normal pH/low GDP solution. The sequence of the two tests was randomized., Results: Fluid transport parameters and glucose absorption were not different between the two groups. No differences were found for the mass transfer area coefficients (MTACs) of low molecular weight solutes calculated over the whole dwell. However, MTAC urea in the first hour of the dwell was higher in the test done with low pH/high GDP dialysate, suggesting more peritoneal vasodilation. No difference was found in protein clearances. Sodium sieving at multiple time points during the dwell was similar with the two solutions., Conclusion: The results obtained with the glucose-containing normal pH/low GDP dialysis solution were similar to those obtained with the glucose-containing low pH/high GDP dialysate in assessments of peritoneal membrane function.
- Published
- 2007
78. Selection and evaluation of adsorbents for the removal of anionic surfactants from laundry rinsing water.
- Author
-
Schouten N, van der Ham LG, Euverink GJ, and de Haan AB
- Subjects
- Adsorption, Anions, Laundering, Surface-Active Agents isolation & purification, Water Pollutants, Chemical isolation & purification
- Abstract
Low-cost adsorbents were tested to remove anionic surfactants from laundry rinsing water to allow re-use of water. Adsorbents were selected corresponding to the different surfactant adsorption mechanisms. Equilibrium adsorption studies of linear alkyl benzene sulfonate (LAS) show that ionic interaction results in a high maximum adsorption capacity on positively charged adsorbents of 0.6-1.7 gLAS/g. Non-ionic interactions, such as hydrophobic interactions of LAS with non-ionic resins or activated carbons, result in a lower adsorption capacity of 0.02-0.6 gLAS/g. Negatively charged materials, such as cation exchange resins or bentonite clay, have negligible adsorption capacities for LAS. Similar results are obtained for alpha olefin sulfonate (AOS). Cost comparison of different adsorbents shows that an inorganic anion exchange material (layered double hydroxide) and activated carbons are the most cost-effective materials in terms of the amount of surfactant adsorbed per dollar worth of adsorbent.
- Published
- 2007
- Full Text
- View/download PDF
79. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.
- Author
-
Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, and Krediet RT
- Subjects
- Biological Transport, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Time Factors, Treatment Failure, Ultrafiltration, Kidney Failure, Chronic therapy, Peritoneal Dialysis
- Abstract
Background: Ultrafiltration failure (UFF) is a major complication of peritoneal dialysis (PD). It can occur at any stage of PD, but develops in time and is, therefore, especially important in long-term treatment. To investigate its prevalence and to identify possible causes, we performed a multicenter study in The Netherlands, where patients treated with PD for more than 4 years were studied using a peritoneal function test (standard peritoneal permeability analysis) with 3.86% glucose. UFF was defined as net UF < 400 mL after a 4-hour dwell., Results: 55 patients unselected for the presence or absence of UFF were analyzed. Mean age was 48 years (range 18 - 74 years); duration of PD ranged from 48 to 144 months (median 61 months); UFF was present in 20 patients (36%). Patients with and without UFF did not differ in age or duration of PD. Median values for patients with normal UF compared to patients with UFF were, for net UF 659 mL versus 120 mL (p < 0.01), transcapillary UF rate 3.8 versus 2.1 mL/ minute (p < 0.01), effective lymphatic absorption 1.0 versus 1.6 mL/min (p < 0.05), mass transfer area coefficient (MTAC) for creatinine 9.0 versus 12.9 mL/min (p< 0.01), dialysate-to-plasma ratio (D/P) for creatinine 0.71 versus 0.86 (p < 0.01), glucose absorption 60% versus 73% (p < 0.01), maximum dip in D/P sodium (as a measure of free water transport) 0.109 versus 0.032 (p < 0.01), and osmotic conductance to glucose 3.0 versus 2.1 microL/min/mmHg (p < 0.05). As causes for UFF, high MTAC creatinine, defined as > 12.5 mL/min, or a glucose absorption > 72%, both reflecting a large vascular surface, a lymphatic absorption rate (LAR) of > 2.14 mL/min, and a decreased dip in D/P sodium of < 0.046 were identified. Most patients had a combination of causes (12 patients), whereas there was only a decreased dip in D/P sodium in 3 patients, only high MTAC creatinine in 1 patient, and only high LAR in 2 patients. We could not identify a cause in 2 patients. Both groups had similar clearances of serum proteins and peritoneal restriction coefficients. However, dialysate cancer antigen 125 concentrations, reflecting mesothelial cell mass, were lower in the UFF patients (2.79 vs 5.38 U/L)., Conclusion: The prevalence of UFF is high in long-term PD. It is caused mainly by a large vascular surface area and by impaired channel-mediated water transport. In addition, these patients also had signs of a reduced mesothelial cell mass, indicating damage of the peritoneum on both vascular and mesothelial sites.
- Published
- 2004
80. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.
- Author
-
Smit W, van den Berg N, Schouten N, Aikens E, Struijk DG, and Krediet RT
- Subjects
- Acute Disease, Adult, Aged, Chronic Disease, Dialysis Solutions pharmacokinetics, Humans, Middle Aged, Osmosis, Osmotic Pressure, Peritoneum metabolism, Ultrafiltration, Peritoneal Dialysis, Continuous Ambulatory adverse effects, Peritonitis etiology, Peritonitis metabolism, Water metabolism
- Abstract
Background: Ultrafiltration failure (UFF) in continuous ambulatory peritoneal dialysis (CAPD) is a transient phenomenon during acute peritonitis and a permanent complication in long-term peritoneal dialysis (PD). The high solute transport rates during acute peritonitis are probably caused by an increased number of perfused peritoneal capillaries. Long-term PD is associated with an increased number of peritoneal microvessels, leading to an enlargement of the anatomic vascular surface area. This leads to high mass transfer area coefficients (MTAC) and to UFF. Impaired conductance to glucose, leading to a reduction in free-water transport, may be a contributing factor to UFF in long-term PD. We hypothesized that UFF during acute peritonitis is, in the absence of permanent structural changes, only caused by an increased vascular surface area, while in long-term patients it is often the result of an increased surface area in combination with an impaired conductance to glucose. Therefore, the peritoneal transport parameters of patients with acute peritonitis were compared to those in long-term PD patients., Methods: A standard peritoneal permeability analysis (SPA) was done in 10 PD patients during the first 48 hours after the diagnosis of peritonitis. The results were compared to those obtained in 10 long-term PD patients matched for the MTAC creatinine. In addition, the results of 8 peritonitis patients were compared with SPA results of 8 recently started PD patients, matched for MTAC creatinine., Results: Peritonitis patients had a deeper maximal dip in D/P sodium, corrected for diffusion, than long-term patients (0.058 vs. 0.039, P < 0.05). Most parameters of peritoneal fluid transport were not different, except that t50 (i.e., the time to reach 50% of the maximum transcapillary ultrafiltration) was reached earlier during the dwell in peritonitis than in long-term PD-128 versus 175 minutes, P < 0.05. This confirmed the difference in the shape of the intraperitoneal volume versus time curve, which was blunted in the long-term patients. No differences were found for the parameters of solute transport between peritonitis patients and recently started patients., Conclusion: In contrast to patients with long-term PD, the osmotic conductance to glucose is unaffected in peritonitis, despite the lower net ultrafiltration caused by high solute transport. This implies that impaired free- water transport in chronic PD must be regarded as a contributing factor to UFF.
- Published
- 2004
- Full Text
- View/download PDF
81. Peritoneal function and assessment of reference values using a 3.86% glucose solution.
- Author
-
Smit W, van Dijk P, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, and Krediet RT
- Subjects
- Adolescent, Adult, Aged, Biological Transport, Creatinine blood, Female, Humans, Male, Middle Aged, Osmolar Concentration, Permeability, Reference Values, Treatment Failure, Ultrafiltration, Dialysis Solutions pharmacokinetics, Glucose pharmacokinetics, Isotonic Solutions pharmacokinetics, Peritoneal Dialysis, Peritoneum metabolism
- Abstract
Background: The most widely used peritoneal function test, the peritoneal equilibration test (PET), is performed with a 2.27% glucose solution. Recently, the International Society for Peritoneal Dialysis committee on ultrafiltration failure (UFF) advised performing the test with 3.86% glucose solution because it is more sensitive for detecting clinically significant UFF. Because no reference values for this test were available, we analyzed the results of standard peritoneal permeability analyses (SPAs) using 3.86% glucose., Methods: The tests were performed in our center on 154 clinically stable peritoneal dialysis (PD) patients that were free of peritonitis for at least 4 weeks. For the assessment of reference values, we used two approaches. In approach A, patients with UFF, defined as net ultrafiltration (UF) < 400 mL/4 hours, were excluded. In approach B, only patients within their first 2 years of PD treatment were included, regardless of net UF. Means and 95% confidence intervals (95% CI) were calculated for the transport parameters of the PET and SPA., Results: Means of normal distribution with 95% CI in approach A were as follows: for 2.0-L exchanges, mass transfer area coefficient (MTAC) for creatinine 8.8 mL/minute (4.7 - 12.7 mL/min), dialysate/plasma ratio (D/P) creatinine 0.70 (0.52 - 0.88), glucose absorption 58% (44% - 72%), dialysate240/initial dialysate ratio of glucose (Dt/D0) 0.28 (0.18- 0.38), net UF 675 mL (375 - 975 mL), and maximal dip in D/P sodium after correction for diffusion from the circulation 0.110 (0.050 - 0.164); for 1.5-L exchanges, MTAC creatinine 7.4 mL/min (3.8 - 11.0 mL/min), D/P creatinine 0.69 (0.52 - 0.86), glucose absorption 62% (52% - 72%), Dt/D0 glucose 0.25 (0.17- 0.32), net UF 551 mL (430 - 670 mL), and maximal dip D/P sodium 0.120 (0.048 - 0.166). In approach B, most of the transport values were similar; however, values for lymphatic absorption were significantly higher [1.52 mL/min (2-L) and 1.40 mL/min (1.5-L), p < 0.01] and values for the maximum dip in D/P sodium were lower [0.101 (2-L) and 0.112 (1.5-L), p > 0.05]. This was probably the result of including patients with UFF in approach B, since these parameters can be causative factors of UFF., Conclusions: A peritoneal transport function test using 3.86% glucose provides data on various aspects of transport. This study gives normal reference values that can be used for analysis of causes of UFF.
- Published
- 2003
82. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function.
- Author
-
Smit W, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, and Krediet RT
- Subjects
- Adult, Aged, Humans, Middle Aged, Peritoneum physiopathology, Sodium metabolism, Dialysis Solutions metabolism, Glucose administration & dosage, Peritoneal Dialysis, Continuous Ambulatory, Peritoneum metabolism
- Abstract
Objective: To assess peritoneal membrane function with respect to fluid transport, parameters of low molecular weight solute transport, and estimations of the function of peritoneal water channels, comparing the results from a 1.36%/1.5% glucose solution with those from a 3.86%/4.25% solution in standardized peritoneal function tests., Design: The study was performed in 40 stable continuous ambulatory peritoneal dialysis (CAPD) patients [median age 50 years (range: 22-74 years); duration of CAPD 9 months (range: 2-45 months)] who underwent two standard peritoneal permeability analyses (SPAs) within 1 month. One SPA used 1.36% glucose; the other, 3.86% glucose. Mass transfer area coefficients (MTACs) and dialysate-to-plasma (D/P) ratios were compared for the two solutions. Also, two different methods of estimating aquaporin-mediated water transport were compared: the sieving of sodium (3.86% glucose) and the difference in net ultrafiltration (deltaNUF), calculated as NUF 3.86% SPA - NUF 1.36% SPA., Results: Median NUF in the 1.36% glucose SPA was -46 mL (range: -582 mL to 238 mL); in the 3.86% SPA, it was 554 mL (range: -274 mL to 1126 mL). The median difference in NUF for the two SPAs was 597 mL (range: 90-1320 mL). No difference between the two solutions was seen for the MTAC of creatinine (11.4 mL/min for 1.36% vs 12.0 mL/min for 3.86%) and absorption of glucose (64% vs 65%, respectively). Also, D/P creatinine was not different: 0.77 (1.36%) and 0.78 (3.86%). However, the ratio of dialysate glucose at 240 minutes and at 0 minutes (Dt/D0) was 0.34 (1.36%) and 0.24 (3.86%), p < 0.01. Values of D/P creatinine from the two glucose solutions were strongly correlated. The intra-individual differences were small and showed a random distribution. Patient transport category was minimally influenced by the tonicity of the dialysate. The minimum D/P Na+ (3.86%) was 0.884, and it was reached after 60 minutes. After correction for Na+ diffusion, D/P Na+ decreased to 0.849 after 120 minutes. The correlation coefficient between the diffusion-corrected D/P Na+ and the deltaNUF was 0.49, p < 0.01. An inverse relationship was present between MTAC creatinine and D/P Na+ (p < 0.01) This correlation can be explained by the rapid disappearance of the osmotic gradient owing to a large vascular surface area. Such a correlation was not present between MTAC creatinine and deltaNUF., Conclusions: We conclude that a standardized 4-hour peritoneal permeability test using 3.86%/4.25% glucose is the preferred method to assess peritoneal membrane function, including aquaporin-mediated water transport. The D/P Na+ after correction for Na+ diffusion is probably more useful for the assessment of aquaporin-mediated water transport than is deltaNUF obtained with 3.86%/4.25% and 1.36%/1.5% glucose-based dialysis solutions.
- Published
- 2000
83. Peritoneal transport characteristics with glucose polymer based dialysate.
- Author
-
Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, and Krediet RT
- Subjects
- Adult, Capillaries metabolism, Dextrins, Humans, Kinetics, Middle Aged, Osmosis, Ultrafiltration, Dialysis Solutions, Glucose, Peritoneal Dialysis, Continuous Ambulatory methods, Polymers
- Abstract
Dialysate fluids containing glucose polymers as osmotic agent are different from the conventional solutions, because they are iso-osmotic to plasma and produce transcapillary ultrafiltration (TCUF) by colloid osmosis. To investigate the effects on fluid and solute kinetics, a comparison was made between a 7.5% glucose polymer based dialysate (icodextrin) and 1.36% and 3.86% glucose based dialysate in 10 stable CAPD patients. In each patient three standard peritoneal permeability analyses (SPA) were done with the osmotic agents and concentrations mentioned above. Dextran 70 was added to the glucose solutions to calculate fluid kinetics. In the glucose polymer SPAs fluid kinetics were calculated from the dilution and disappearance of dextrin. The TCUF rate with icodextrin was closer to that obtained with 3.86% glucose than to 1.36% glucose. Extrapolation of the fluid profiles revealed sustained ultrafiltration with icodextrin. TCUF increased linearly in time in the icodextrin tests, whereas a hyperbola best described the glucose profiles. The effective lymphatic absorption rate with icodextrin was similar to the glucose based solutions. Mass transfer area coefficients of low molecular weight solutes with icodextrin were also similar to the values obtained with glucose, as was D/P creatinine. A positive correlation was present between the MTAC creatinine and the TCUF rate with icodextrin (r = 0.66, P = 0.05), which was absent in the glucose SPAs. This suggests that in patients with a larger effective peritoneal surface area, more ultrafiltration can be achieved by glucose polymer solutions. Clearances of beta 2-microglobulin (beta 2m) were higher with icodextrin than with 3.86% glucose and 1.36% glucose dialysate (P < 0.05). No differences were found for the larger serum proteins albumin, IgG and alpha 2-macroglobulin. Initial D/PNa-->was higher (0.96) with icodextrin than with the glucose based solutions (0.92), due to the higher Na+ concentration of icodextrin, and it remained unchanged during the dwell. In contrast, D/PNa+ of 1.36% glucose increased during the dwell, whereas D/PNa+ decreased with 3.86% glucose until 60 minutes, followed by a subsequent increase. The ultrafiltration coefficient (UFC) of the total peritoneal membrane was assessed using 3.86% glucose (0.18 +/- 0.04 ml/min/mm Hg), and the UFC of the small pores was assessed using icodextrin (0.06 +/- 0.008 ml/min/mm Hg). The difference between these represented the UFC through the transcellular pores, which averaged 50.5% of the total UFC, but with a very wide range (0 to 85%). An inverse relation existed between the duration of CAPD treatment and the total ultrafiltration coefficient (r = -0.68, P < 0.04), which could be attributed to a lower UFC of the transcellular pores in long-term patients (r = -0.66, P < 0.05), but not to the UFC of the small pores (r = -0.48, NS). The TCUFRo-60 min through the transcellular pores correlated with the sodium gradient, corrected for diffusion, in the first hour of the dwell (r = 0.69, P < 0.04), indicating that both parameters indeed measure transcellular water transport. It can be concluded that the glucose polymer solution induced sustained ultrafiltration and had no effect on peritoneal membrane characteristics. In addition, the results of the present study support the hypothesis that the glucose polymer solutions exerts its osmotic pressure across intercellular pores with radii of about 40 A. This leads to increased clearances of low molecular weight proteins such as beta 2m that are transported through these pores without sieving of Na+. The latter, as found during 3.86% glucose dialysate, is probably caused by transcellular water transport. The transcellular water transport accounted for 50% of the total ultrafiltration with glucose based dialysis solutions. It was lower in long-term CAPD patients.
- Published
- 1996
- Full Text
- View/download PDF
84. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.
- Author
-
Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, de Waart R, Hiralall J, and Krediet RT
- Subjects
- Adult, Aged, Aged, 80 and over, Humans, Middle Aged, Permeability, Ultrafiltration, Peritoneal Dialysis, Continuous Ambulatory, Peritoneum metabolism
- Abstract
Peritoneal transport characteristics in CAPD patients are often assessed by the peritoneal equilibration test (PET), which uses a four hour dwell with glucose 2.27% dialysate. From the test, the dialysate/plasma ratio of creatinine (D/PCr), the dialysate/initial dialysate ratio of glucose (D/Do) and net ultrafiltration (NUF, drained minus instilled volume) are calculated. The standard peritoneal permeability analysis (SPA) is a modification and extension of the PET: glucose 1.36% dialysate is used, to which dextran 70 (1 g/liter) is added for the calculation of fluid kinetics. Mass transfer area coefficients (MTAC's) of low molecular weight solutes, clearances of proteins and the change in intraperitoneal volume (delta IPV) can be assessed. In this study the SPA was analyzed, and a comparison with the PET was made. A total number of 138 SPA's was analyzed in 86 different clinically stable patients. Normal values were calculated for both SPA and PET parameters in the same tests. Median (ranges) of comparable transport parameters from SPA and PET were: MTACCr, 10.4 ml/min (5.7 to 19.3); glucose absorption, 61% (35 to 87); delta IPV, 9.5 ml (-761 to 310); D/PCr, 0.76 (0.53 to 1.14); D/D0, 0.37 (0.13 to 0.56); NUF, -75 ml (-675 to 450). The agreement between SPA and PET was analyzed using the method of Bland and Altman. A fairly good agreement was present between NUF and delta IPV. Systematic errors were found when D/PCr and MTACCr were compared: D/P overestimated MTAC mainly in the low range, whereas in the high range values were underestimated. A similar pattern was seen for the transport parameters of glucose. In 40 patients negative net ultrafiltration was present, and possible reasons for this were assessed. In 9 patients no reason could be identified. It can be concluded that the SPA provides useful and extensive information on peritoneal transport parameters. Compared to the PET, the SPA has better discriminative power for the transport of glucose and creatinine.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.